| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Changes in ophthalmopathy | |||||
|
RCT 3-armed trial |
150 people with Graves' disease Subgroup analysis |
Proportion of people with improvement in Graves' ophthalmopathy
22/31 (71%) with total thyroidectomy 21/29 (72%) with bilateral subtotal thyroidectomy (total remnant <4 mL) 20/29 (69%) with unilateral total thyroidectomy plus contralateral subtotal thyroidectomy (remnant <4 mL) |
P >0.05 among groups |
Not significant | |
|
RCT 3-armed trial |
150 people with Graves' disease Subgroup analysis |
Proportion of people with documented improvement of eye symptoms
71% with total thyroidectomy 74% with bilateral subtotal thyroidectomy (total remnant <4 mL) 74% with unilateral total thyroidectomy plus contralateral subtotal thyroidectomy (remnant <4 mL) Absolute numbers not reported |
P >0.05 among groups |
Not significant | |
|
RCT 3-armed trial |
150 people with Graves' disease Subgroup analysis |
Reduction in Graves' opthalmopathy score (American Thyroid Association scale; 0 = best, 40 = worst)
–2.0 with total thyroidectomy –2.5 with bilateral subtotal thyroidectomy (total remnant <4 mL) –2.0 with unilateral total thyroidectomy plus contralateral subtotal thyroidectomy (remnant <4 mL) Absolute numbers not reported |
P >0.05 among groups |
Not significant |